A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.

The accumulation of eosinophils in inflammatory foci is a hallmark characteristic of Th2 inflammation. Nevertheless, the expression of inhibitory receptors such as paired immunoglobulin-like receptor B (PIR-B) and their function regulating eosinophil accumulation have received limited attention. We now report that Pirb was up-regulated in an eosinophil-dependent manner in the lungs of allergen-challenged and interleukin (IL)-13-overexpressing mice. Eosinophils expressed high levels of PIR-B, and Pirb(-/-) mice displayed increased gastrointestinal eosinophils. Consistent with these findings, PIR-B negatively regulated eotaxin-dependent eosinophil chemotaxis in vivo and in vitro. Surprisingly, Pirb(-/-) eosinophils and neutrophils had decreased leukotriene B4 (LTB(4))-dependent chemotactic responses in vitro. Furthermore, eosinophil accumulation was decreased in a chitin-induced model, partially dependent on LTB(4). Mechanistic analysis using a miniphosphoproteomic approach revealed that PIR-B recruits activating kinases after LTB(4) but not eotaxin stimulation. Consequently, eotaxin-activated Pirb(-/-) eosinophils displayed markedly increased extracellular signal-related kinase 1 and 2 (ERK1/2) phosphorylation, whereas LTB(4)-activated eosinophils had reduced ERK1/2 phosphorylation. We provide multiple lines of evidence supporting a model in which PIR-B displays opposing but potent regulatory functions in granulocyte activation. These data change the conventional wisdom that inhibitory receptors are restricted to inhibitory signals; we therefore propose that a single receptor can have dual functionality in distinct cell types after unique cellular signals.

[1]  James J. Lee,et al.  Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? , 2007, The Journal of allergy and clinical immunology.

[2]  S. Phipps,et al.  Eosinophil trafficking in allergy and asthma. , 2007, The Journal of allergy and clinical immunology.

[3]  Francesca Levi-Schaffer,et al.  Inhibitory receptors on eosinophils: a direct hit to a possible Achilles heel? , 2007, The Journal of allergy and clinical immunology.

[4]  D. Voehringer,et al.  Chitin induces accumulation in tissue of innate immune cells associated with allergy , 2007, Nature.

[5]  M. Rothenberg,et al.  Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. , 2006, The American journal of pathology.

[6]  A. Kowalski-Chauvel,et al.  An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway. , 2006, Biochimica et biophysica acta.

[7]  J. Trowsdale,et al.  You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling , 2006, European journal of immunology.

[8]  Nikolaos M. Nikolaidis,et al.  Persistent effects induced by IL-13 in the lung. , 2006, American journal of respiratory cell and molecular biology.

[9]  I. Bachelet,et al.  The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. , 2006, Blood.

[10]  M. Rothenberg,et al.  The eosinophil. , 2006, Annual review of immunology.

[11]  T. K. van den Berg,et al.  Signal Regulatory Protein α Ligation Induces Macrophage Nitric Oxide Production through JAK/STAT- and Phosphatidylinositol 3-Kinase/Rac1/NAPDH Oxidase/H2O2-Dependent Pathways , 2005, Molecular and Cellular Biology.

[12]  T. Takai Paired immunoglobulin‐like receptors and their MHC class I recognition , 2005, Immunology.

[13]  Takao Shimizu,et al.  Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2 , 2005, Journal of Biological Chemistry.

[14]  Nikolaos M. Nikolaidis,et al.  Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation* , 2005, Journal of Biological Chemistry.

[15]  Hong Zhang,et al.  The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. , 2005, Immunity.

[16]  R. Zipser,et al.  Role of eicosanoids in human and experimental colitis , 1988, Digestive Diseases and Sciences.

[17]  Hong Zhang,et al.  The Inhibitory Receptor PIR-B Negatively Regulates Neutrophil and Macrophage Integrin Signaling1 , 2004, The Journal of Immunology.

[18]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[19]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[20]  J. L. Kavanaugh,et al.  Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-γ (Mig, CXCL9) , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Foster,et al.  Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. , 2003, The Journal of allergy and clinical immunology.

[22]  C. Lowell,et al.  The Lyn Tyrosine Kinase Negatively Regulates Neutrophil Integrin Signaling 1 , 2003, The Journal of Immunology.

[23]  Qutayba Hamid,et al.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.

[24]  B. Bochner,et al.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.

[25]  D. Cosman,et al.  Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. P. Sidorenko,et al.  The dual-function CD150 receptor subfamily: the viral attraction , 2003, Nature Immunology.

[27]  C. Lowell,et al.  Fgr Deficiency Results in Defective Eosinophil Recruitment to the Lung During Allergic Airway Inflammation1 , 2002, The Journal of Immunology.

[28]  A. Nakamura,et al.  Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice , 2002, Nature Immunology.

[29]  P. Foster,et al.  IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. , 2001, The Journal of allergy and clinical immunology.

[30]  M. Cooper,et al.  Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. , 2001, The Journal of clinical investigation.

[31]  P. Foster,et al.  A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation , 2001, Nature Immunology.

[32]  A. McKenzie,et al.  Elemental signals regulating eosinophil accumulation in the lung , 2001, Immunological reviews.

[33]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[34]  U. V. von Andrian,et al.  Bltr Mediates Leukotriene B4–Induced Chemotaxis and Adhesion and Plays a Dominant Role in Eosinophil Accumulation in a Murine Model of Peritonitis , 2000, The Journal of experimental medicine.

[35]  P. Foster,et al.  A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Lindsay,et al.  Pleiotropic role of lyn kinase in leukotriene B(4)-induced eosinophil activation. , 2000, Blood.

[37]  S. Stafford,et al.  Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. , 2000, Blood.

[38]  C. Chen,et al.  Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Suda,et al.  Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis. , 1999, Biochemical and biophysical research communications.

[40]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[41]  M. Ono,et al.  Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. , 1998, Journal of immunology.

[42]  M. Lindsay,et al.  Role of the mitogen‐activated protein kinases and tyrosine kinases during leukotriene B4‐induced eosinophil activation , 1998, Journal of leukocyte biology.

[43]  A. Luster,et al.  Molecular and Biological Characterization of the Murine Leukotriene B4 Receptor Expressed on Eosinophils , 1998, The Journal of experimental medicine.

[44]  T. Adachi,et al.  The mechanism of IL-5 signal transduction. , 1998, The American journal of physiology.

[45]  W. Busse Leukotrienes and inflammation. , 1998, American journal of respiratory and critical care medicine.

[46]  T. Kurosaki,et al.  Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal , 1998, The Journal of experimental medicine.

[47]  M. Cooper,et al.  A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[49]  S. Stafford,et al.  The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. , 1995, Journal of immunology.

[50]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[51]  L. Koenderman,et al.  Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes. , 1993, The Journal of allergy and clinical immunology.

[52]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.